搜索临床试验以:NBL-012注射剂
总计12495个结果
-
M.D. Anderson Cancer Center撤销类癌综合征 | 晚期神经内分泌肿瘤
-
Aphaia Pharma US LLC招聘中
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics Biotech招聘中解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 三阴性乳腺癌 | 转移性三阴性乳腺癌 | 局部晚期乳腺癌美国
-
Aphaia Pharma US LLCNovaClin Medical Research Center S.R.L; ACC GmbH Analytical Clinical Concepts; SC Bioclinica SA; Galephar Pharmaceutical Research (PR), Inc...完全的
-
Nanjing Leads Biolabs Co.,LtdHenan Cancer Hospital; Hunan Cancer Hospital; Shandong Cancer Hospital and Institute完全的
-
University of California, San DiegoCalifornia Institute for Regenerative Medicine (CIRM); n-Lorem Foundation主动,不招人
-
Keros Therapeutics, Inc.招聘中
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences Institute完全的
-
Diwakar DavarTesaro, Inc.招聘中
-
LaNova Medicines Development Co., Ltd.Shanghai Zhongshan Hospital; First Affiliated Hospital of Zhejiang University; Sir Run Run Shaw... 和其他合作者终止
-
Promontory Therapeutics Inc.主动,不招人泌尿生殖系统肿瘤 | 按部位分类的肿瘤 | 生殖器肿瘤,男性 | 前列腺肿瘤 | 晚期实体瘤 | mCRPC | 转移性去势抵抗性前列腺癌 | CRPC | PT-112美国, 法国
-
Combangio, IncKala Pharmaceuticals, Inc.招聘中
-
Raziel Therapeutics Ltd.Spaulding Clinical Research LLC完全的
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)完全的